Novartis AG (NVS) Stock Valuation: P/E Ratio and Intrinsic Value
Is Novartis AG stock expensive or cheap? This page shows the price-earnings ratio of Novartis AG for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings (FY 2025).
Earnings basis for the valuation (FY 2025)
| Revenue | 54.53 USD bn |
|---|---|
| Net income | 13.98 USD bn |
| Net margin | 25.6 % |
How the Novartis AG P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Novartis AG is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Novartis AG
What is the NVS P/E ratio?
The P/E ratio divides the Novartis AG share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of NVS can be compared with its own history.
Is Novartis AG stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of NVS is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Novartis AG?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of NVS as the starting point.